Overview
Autosomal recessive hereditary demyelinating motor and sensory neuropathy is a group of inherited peripheral nerve disorders characterized by progressive damage to the myelin sheath — the protective covering surrounding peripheral nerves. This condition falls within the broader category of Charcot-Marie-Tooth disease (CMT), specifically the demyelinating forms inherited in an autosomal recessive pattern, often referred to as CMT4 or AR-CMT demyelinating type. The disease primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of the distal muscles (particularly in the feet, lower legs, hands, and forearms), sensory loss, reduced or absent deep tendon reflexes, and foot deformities such as pes cavus (high-arched feet) and hammer toes. Nerve conduction velocities are significantly reduced due to the demyelinating process. The onset is typically in childhood, and the disease tends to be more severe than autosomal dominant forms of CMT. Patients may experience difficulty walking, frequent tripping, and progressive gait abnormalities. Some subtypes may also feature scoliosis, vocal cord paresis, or cranial nerve involvement depending on the specific genetic cause. Multiple genes have been implicated in autosomal recessive demyelinating CMT, including GDAP1, MTMR2, SBF2, SH3TC2, NDRG1, EGR2, PRX, and others, each defining a specific CMT4 subtype. Diagnosis is based on clinical examination, electrophysiological studies showing reduced nerve conduction velocities consistent with demyelination, and genetic testing to identify the causative mutation. There is currently no cure for this condition. Treatment is supportive and multidisciplinary, including physical therapy to maintain muscle strength and flexibility, occupational therapy, orthotic devices (such as ankle-foot orthoses) to improve mobility, and surgical interventions for skeletal deformities when necessary. Pain management and regular monitoring by a neurologist are important components of ongoing care. Genetic counseling is recommended for affected families.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Autosomal recessive hereditary demyelinating motor and sensory neuropathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal recessive hereditary demyelinating motor and sensory neuropathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal recessive hereditary demyelinating motor and sensory neuropathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal recessive hereditary demyelinating motor and sensory neuropathy.
Community
No community posts yet. Be the first to share your experience with Autosomal recessive hereditary demyelinating motor and sensory neuropathy.
Start the conversation →Latest news about Autosomal recessive hereditary demyelinating motor and sensory neuropathy
No recent news articles for Autosomal recessive hereditary demyelinating motor and sensory neuropathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal recessive hereditary demyelinating motor and sensory neuropathy
What is Autosomal recessive hereditary demyelinating motor and sensory neuropathy?
Autosomal recessive hereditary demyelinating motor and sensory neuropathy is a group of inherited peripheral nerve disorders characterized by progressive damage to the myelin sheath — the protective covering surrounding peripheral nerves. This condition falls within the broader category of Charcot-Marie-Tooth disease (CMT), specifically the demyelinating forms inherited in an autosomal recessive pattern, often referred to as CMT4 or AR-CMT demyelinating type. The disease primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of the distal muscles (particul
How is Autosomal recessive hereditary demyelinating motor and sensory neuropathy inherited?
Autosomal recessive hereditary demyelinating motor and sensory neuropathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal recessive hereditary demyelinating motor and sensory neuropathy typically begin?
Typical onset of Autosomal recessive hereditary demyelinating motor and sensory neuropathy is childhood. Age of onset can vary across affected individuals.